Regional, geographic, and ethnic differences in medication adherence among adults with type 2 diabetes

Annals of Pharmacotherapy

Volumn 45, Issue 2, 2011, Pages 169-178

  Egede, Leonard E ^a,b,c   Gebregziabher, Mulugeta ^a,d   Hunt, Kelly J ^a,d   Axon, Robert N ^a,b   Echols, Carrae ^a   Gilbert, Gregory E ^a   Mauldin, Patrick D ^a,e  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Center for Health Disparities Research   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cohort; Diabetes mellitus; Health disparities; Medication adherence

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; CALCULATION; CONTROLLED STUDY; DEATH; DIABETIC PATIENT; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GEOGRAPHY; HISPANIC; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RACE DIFFERENCE; RURAL AREA; UNITED STATES; URBAN AREA; VETERAN; BLACK PERSON; CAUCASIAN; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 2; DRUG COMBINATION; ETHNOLOGY; GLUCOSE BLOOD LEVEL; MEDICATION COMPLIANCE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RURAL POPULATION; STATISTICS AND NUMERICAL DATA; URBAN POPULATION;

ADMINISTRATION, ORAL; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RURAL POPULATION; URBAN POPULATION; VETERANS;

EID: 79951877201     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P442     Document Type: Article

References (52)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and estimates on diabetes in the United States, 2007. Atlanta: US Department of Health and Human Services, 2007.
2. Dall TM, Zhang Y, Chen YJ, Quick WW, Yang WG, Fogli J. The economic burden of diabetes. Health Aff (Millwood) 2010;29:297-303.
3. Economic costs of diabetes in the US in 2007. Diabetes Care 2007;31: 596-615.
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86.
5. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854-65. DOI S0140673698070378
6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53. DOI S0140673698070196
7. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12. (Pubitemid 30609442)
8. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999;281:2005-12. DOI joc72221
9. Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 2006;144:465-74. DOI 144/7/465
10. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 2002;136:565-74. DOI 200204160-00005
11. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002;25:1015-21. (Pubitemid 41110487)
12. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-30. DOI 00005650-200506000-00002
13. Menzin J, Langley-Hawthorne C, Friedman M, Boulanger L, Cavanaugh R. Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care 2001;24:51-5. (Pubitemid 32104219)
14. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clinical Ther 2003;25:2958-71. DOI S0149291803803478
15. Kim N, Agostini JV, Justice AC. Refill adherence to oral hypoglycemic agents and glycemic control in veterans. Ann Pharmacother 2010;44: 800-8. DOI 10.1345/aph.1M570
16. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004;27:1218-24. (Pubitemid 38579798)
17. Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educator 2007;33:1014-29; discussion 30-1. DOI 10.1177/0145721707308407
18. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 1999;22:403-8. (Pubitemid 29106894)
19. Eberhardt MS, Lackland DT, Wheeler FC, German RR, Teutsch SM. Is race related to glycemic control? An assessment of glycosylated hemoglobin in two South Carolina communities. J Clin Epidemiol 1994;47: 1181-9. DOI 0895-4356(94)90105-8
20. Gary TL, McGuire M, McCauley J, Brancati FL. Racial comparisons of health care and glycemic control for African American and white diabetic adults in an urban managed care organization. Dis Manag 2004;7:25-34. DOI 10.1089/109350704322918970 (Pubitemid 38436640)
21. Shenolikar RA, Balkrishnan R. Oral antidiabetes medication adherence and health care utilization among Medicaid-enrolled type 2 diabetic patients beginning monotherapy. Diabetes Care 2008;31:e5. (Pubitemid 351213357)
22. Cramer JA, Pugh MJ. The influence of insulin use on glycemic control: How well do adults follow prescriptions for insulin? Diabetes Care 2005;28:78-83. DOI 28/1/78
23. Fisher E, Goodman D, Skinner J, Bronner K. Health care spending, quality, and outcomes: more isn't always better. The Dartmouth Atlas Project 2009. Lebanon, NH: The Trustees of Dartmouth College, 2009.
24. Wennberg JE. The quality of medical care in the United States: a report on the Medicare program. Hanover, NH: The Center for the Evaluative Clinical Sciences Dartmouth Medical School, 1999.
25. Subramanian U, Weinberger M, Eckert GJ, L'Italien GJ, Lapuerta P, Tierney W. Geographic variation in health care utilization and outcomes in veterans with acute myocardial infarction. J Gen Intern Med 2002;17:604-11. DOI jgi11048
26. Tseng CL, Helmer D, Rajan M, et al. Evaluation of regional variation in total, major, and minor amputation rates in a national health-care system. Int J Qual Health Care 2007;19:368-76. DOI 10.1093/intqhc/mzm044 (Pubitemid 350186971)
27. Williams LS, Eckert GJ, L'Italien GJ, Lapuerta P, Weinberger M. Regional variation in health care utilization and outcomes in ischemic stroke. J Stroke Cerebrovasc Dis 2003;12:259-65. DOI 10.1016/j.jstrokecerebrovasdis.2003.09.008 (Pubitemid 38057897)
28. Larson SL, Fleishman JA. Rural-urban differences in usual source of care and ambulatory service use: analyses of national data using Urban Influence Codes. Med Care 2003;41:III65-74. DOI 10.1097/01.MLR.0000076053.28108.F2
29. Rosenthal TC, Fox C. Access to health care for the rural elderly. JAMA 2000;284:2034-6.
30. van Dis J. MSJAMA. Where we live: health care in rural vs urban America. JAMA 2002;287:108. DOI jms0102-2
31. Weeks WB, Kazis LE, Shen Y, et al. Differences in health-related quality of life in rural and urban veterans. Am J Public Health 2004;94:1762-7. DOI 94/10/1762
32. Weeks WB, Lee RE, Wallace AE, West AN, Bagian JP. Do older rural and urban veterans experience different rates of unplanned readmission to VA and non-VA hospitals? J Rural Health 2009;25:62-9. DOI 10.1111/j.1748-0361.2009. 00200.x
33. Morgan RO, Petersen LA, Hasche JC, et al. VHA pharmacy use in veterans with Medicare drug coverage. Am J Manag Care 2009;15:e1-8.
34. Shen Y, Hendricks A, Zhang S, Kazis LE. VHA enrollees' health care coverage and use of care. Med Care Res Rev 2003;60:253-67. (Pubitemid 36605436)
35. Zhu SC, Gardner JA, Hendricks A. How many enrollees come to VA just for pharmacy? Health Care Financing and Economics Data Brief #2004- 10. www.hcfe.research.va.gov (accessed 2010 Oct 8).
36. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004;27(suppl 2):B10-21.
37. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care 2008;46: 1125-33. DOI 10.1097/MLR.0b013e31817924d2
38. West AN, Lee RE, Shambaugh-Miller MD, et al. Defining "rural" for veterans' health care planning. J Rural Health 2010;26:301-9. DOI 10.1111/j.1748-0361.2010.00298.x
39. Department of Veterans Affairs Field Research Advisory Committee. (2004). Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Field Research Advisory Committee Operating Procedures. Washington, DC: 2004.
40. Diggle P, Liang K, Zeger S. Analysis of longitudinal data. vol 25. 2nd ed. New York: Oxford University Press, 2002.
41. Donnelly LA, Morris AD, Evans JM. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM 2007;100:345-50. DOI 10.1093/qjmed/hcm031 (Pubitemid 47073810)
42. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006;166:1836-41. DOI 10.1001/archinte.166.17.1836 (Pubitemid 44455165)
43. Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care;48:409-17. DOI 10.1097/MLR. 0b013e3181d68978
44. Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med 2002;19:279-84. DOI 10.1046/j.1464-5491. 2002.00689.x (Pubitemid 34592152)
45. Doro P, Benko R, Kosik E, Matuz M, Toth K, Soos G. Utilization of oral antihyperglycemic drugs over a 7-year period (1998-2004) in a Hungarian population and adherence to drug therapy. Eur J Clin Pharmacol 2005;61:893-7. DOI 10.1007/s00228-005-0031-9
46. Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther 2005;27:1064-73. DOI 10.1016/j.clinthera.2005.07.009 (Pubitemid 41262464)
47. Kalsekar ID, Madhavan SS, Amonkar MM, et al. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents. Ann Pharmacother 2006;40:605-11. DOI 10.1345/aph.1G606
48. Rhee MK, Slocum W, Ziemer DC, et al. Patient adherence improves glycemic control. Diabetes Educ 2005;31:240-50. DOI 10.1177/0145721705274927 (Pubitemid 40529013)
49. Sclar DA, Robison LM, Skaer TL, Dickson WM, Kozma CM, Reeder CE. Sulfonylurea pharmacotherapy regimen adherence in a Medicaid population: influence of age, gender, and race. Diabetes Educ 1999;25: 531-2, 535, 537-8.
50. Rosen MI, Beauvais JE, Rigsby MO, Salahi JT, Ryan CE, Cramer JA. Neuropsychological correlates of suboptimal adherence to metformin. J Behav Med 2003;26:349-60. (Pubitemid 36890201)
51. Gerber BS, Cho YI, Arozullah AM, Lee SY. Racial differences in medication adherence: a cross-sectional study of medicare enrollees. Am J Geriatr Pharmacother 2010;8:136-45. DOI 10.1016/j.amjopharm.2010.03.002
52. Venturini F, Nichol MB, Sung JC, Bailey KL, Cody M, McCombs JS. Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother 1999;33:281-8. DOI 10.1345/aph.18198 (Pubitemid 29157736)